Tag: Medicare Part B reimbursement
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Breastfeeding Medication Timing: How to Reduce Infant Drug Exposure
Dec, 4 2025
Panmycin (Tetracycline) vs Alternative Antibiotics: Detailed Comparison
Oct, 17 2025
Pulmonary Function Tests: How to Interpret Spirometry and DLCO Results
Dec, 9 2025
Actos: Everything You Need to Know About Pioglitazone for Type 2 Diabetes
Jun, 5 2025
Prednisone Alternatives in 2025: 8 Options You Should Know
Apr, 22 2025